F-Prime Capital Partners vs Sofinnova Ventures
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| F-Prime Capital Partners | Sofinnova Ventures | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Cambridge | Menlo Park |
| Founded | 2002 | 1976 |
| Check size | $3M – $10M | $100K – $15M |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS | Biotech, Digital Health, Healthtech, Medical Devices |
| AUM | $13B | $5.4B |
| Tracked investments | 378 | 177 |
| Exits (acquired/public) | 6 | 3 |
| Led rounds on record | — | 1 |
| Dated deals, last 24 mo | 5 | 6 |
Shared portfolio · 6
Aclaris TherapeuticsCoherus BiosciencesNextwavepharmaOncusp TherapeuticsApellisProteostasis Therapeutics
Frequently asked questions
- Do F-Prime Capital Partners and Sofinnova Ventures invest together?
- Yes — F-Prime Capital Partners and Sofinnova Ventures appear together in 6 tracked portfolio companies, including Aclaris Therapeutics, Coherus Biosciences, Nextwavepharma, Oncusp Therapeutics, Apellis.
- How do F-Prime Capital Partners and Sofinnova Ventures compare on check size?
- F-Prime Capital Partners typically writes checks of $3M – $10M, while Sofinnova Ventures writes $100K – $15M.